FDA issues warning to dietary supplements making unproven claims

Robert K. Chin/Alamy

On February 11, the FDA issued a statement and 12 warning letters related to an aggressive change in the agency’s regulation of dietary supplements. The statement was outlined in the New York Times. The main objective of the new approach is enhanced protection of consumers from mislabeled and unproven claims about treatment of disease. At the core of the problem are a number of companies that specifically target people with Alzheimer’s disease and people who are concerned about developing Alzheimer’s disease. A list of the companies receiving warning letters, as well as links to the letters, can be found here.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.